Statins may lower risk of chemotherapy induced heart failure in breast cancer patients
Researchers have found in a new observational study that Women who take statins during chemotherapy with anthracyclines for early-stage breast cancer are half as likely to require emergency department visits or hospitalization for heart failure in the 5 years after chemotherapy. Further there was evidence that women taking statins may have a lower risk of heart failure after receiving the breast cancer medication trastuzumab.
Researchers say statin use should be encouraged in women starting potentially heart-toxic treatments for early-stage breast cancer if they already have indications to take them for heart disease prevention. However, clinical trials are still needed to determine whether all women with breast cancer should be prescribed statins during chemotherapy that may harm the heart.
The new study has been published in the Journal of the American Heart Association.